Dapagliflozin Anhydro Impurity

Dapagliflozin Anhydro Impurity or 6-(3-(4-Ethoxybenzyl)-4-chlorophenyl)-2-(hydroxymethyl)-3,4-dihydro-2H-pyran-3,4-diol is a potential impurity of Dapagliflozin which is a novel class of glucose-lowering agents known as sodium-glucose co-transporter-2 (SGLT2) blocker and is evaluated for use in the cure of patients with type 2 diabetes.

Additional information

Catalogue No.

VE007777

CAS No.

N/A

Molecular Formula

C21H23ClO5

Molecular Weight

390.86 g/mol

IUPAC Name

6-(3-(4-Ethoxybenzyl)-4-chlorophenyl)-2-(hydroxymethyl)-3, 4-dihydro-2H-pyran-3, 4-diol

References

Deepan, Thiyagarajan, and Magharla Dasaratha Dhanaraju. “Stability Indicating HPLC Method for the Simultaneous Determination of Dapagliflozin and Saxagliptin in Bulk and Tablet Dosage Form.” Current Issues in Pharmacy and Medical Sciences, vol. 31, no. 1, Mar. 2018, pp. 39–43, https://doi.org/10.1515/cipms-2018-0009 Plosker, Greg L. “Dapagliflozin.” Drugs, vol. 72, no. 17, Dec. 2012, pp. 2289–312, https://doi.org/10.2165/11209910-000000000-00000.?

Status

In-stock